Nimodipine

  • TRADE NAMES: Admon; Nimotop (Bayer); Periplum; Vasotop
  • INDICATIONS: Subarachnoid hemorrhage
  • CLASS: Calcium channel blocker
  • HALF-LIFE: 3 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Amprenavir, Delavirdine, Epirubicin, Imatinib

PREGNANCY CATEGORY: C

Our database has 15 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
OTHER.


Page last updated 08/02/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top